Jörg Breitkreutz is a pharmacist by training and finished his PhD in 1996 at the Institute for Pharmaceutical Technology and Biopharmaceutics in Münster under supervision of Prof. Gröning.

From 1996 to 1997 he joined Thiemann Arzneimittel GmbH in Waltrop, Germany, and from 1997 to 2004 the University of Münster to work on his habilitation on paediatric drug formulations.
In 2004 he became professor for pharmaceutical technology at the Heinrich-Heine-University in Düsseldorf, Germany.
Since 2010 he is the president of the International Association of Pharmaceutical Technology (APV).

His research focuses on paediatric drug formulations, orphan drugs and process analytical technologies.

Dr. Markus Dachtler studied chemistry in Tübingen, Germany and economics in Neu-Ulm, Germany. In 2000 he finished his Ph.D. thesis in analytical chemistry in Tübingen dealing with direct LC-NMR-MS coupling analysis of biomedicals.

From 2000-2004 Dr. Markus Dachtler was employed as scientist at Unilever R&D, Vlaardingen, the Netherlands.
From 2004-2015 he joined ratiopharm (since 2010 within Teva group), Ulm, Germany and worked in different departments (Stability control, R&D Project Management, General Management).
In June 2015 Dr. Markus Dachtler acquired Gen-Plus GmbH & Co KG in Munich, Germany. Dr Dachtler is also co-founder of the company DiHeSys – Digital Health Systems. The company is a healthcare provider for personalized medication.

Dr. Dachtler gives regular lectures in the field of generics development and pharma business. He has authored more than 20 publications in international journals and also holds 1 patent.

In his scientific career he got several innovation awards and the Richard R. Ernst Prize in 1998.

Elke Sternberger-Rützel studied pharmacy at the FU Berlin and Eberhard-Karls-Universität Tübingen until 1998. Thereafter she started 1998 to earned her doctorate in Pharmaceutical Technology at the Karl Ruprecht University Heidelberg. She is also a pharmacist specializing in pharmaceutical technology. After completing her doctorate, she worked in the pharmaceutical development department of Grünenthal GmbH (2002-2006) as laboratory manager for packaging development, stability studies and packaging of clinical test samples. Later in the R & D department of Catalent Pharma Solution (Schorndorf, Germany) (2006-2009) as a packaging developer with a focus on microdosing, as interim head of department and project manager. Subsequently, she was hired as Pharma Trendscout and Innovation Manager at Robert Bosch Gmbh Packaging Pharma (2009-2012). Since 2013 she has been working for Harro Höfliger GmbH as Head of Test Facilities within Pharma Services.